GUANGYUAN, CHINA - Media OutReach Newswire - 24 March 2025 - On March 12, marking the 47th Arbor Day of China, the 'Shu Road ...

It was not until the latter half of 1971, when pharmaceutical chemist Tu Youyou was rereading the Zhou Hou Bei Ji Fang as ...

Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region ...

NVIDIA's previous-gen GeForce RTX 4090 modded with 48GB of RAM in China, sells for $3400 with AIO cooler, 96GB model is for ...

GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song ...

GE HealthCare is bringing in a 20-year Johnson & Johnson executive to serve as president and CEO in China when its current leader, Yihao Zhang, retires July 1. Will Song, who served as global ...

High-energy particle accelerators, such as CERN’s Proton Synchrotron and Brookhaven’s Alternating Gradient Synchrotron, were regarded as the most exciting, well-funded and biggest instruments in ...

China's central bank has tweaked the pricing for one-year loans to commercial lenders , a move seen as a fresh sign that it is loosening its monetary stance under a policy revamp. The change ...

Investing.com -- Goldman Sachs raised rating on GE HealthCare Technologies Inc (NASDAQ: GEHC) to "Buy" from "Neutral” as China’s healthcare market is showing signs of stabilization, with demand for ...

Goldman Sachs upgraded GE Healthcare to Buy, raising its price target from $85 to $100. Analysts expect China sales to recover to 2023 levels by 2026, two years earlier than previously forecast.